How Amyotrophic Lateral Sclerosis Contributes to Increased Venous Thromboembolism Risk

##plugins.themes.academic_pro.article.sidebar##

Published Mar 2, 2025
https://doi.org/10.62438/tunismed.v103i3.5734
Download
pdf
Vol. 103 No. 3 (2025): Tunis Med Mar 2025

##plugins.themes.academic_pro.article.main##

Abdullah Ashraf Hamad
Faculty of Medicine, Menoufia University, Menoufia, Egypt. Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA

Abstract

.

Keywords:

amyotrophic lateral sclerosis, anticoagulant, neurodegenerative diseases, pulmonary embolism, venous thromboembolism

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Immobile ALS patients or those at risk of venous thromboembolism require a comprehensive examination and low-dose heparinisation. Tunis Med.
  2. Hamad AA, Alkhawaldeh IM, Abbas A, et al. Incidence and risk factors of venous thromboembolism in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Tunis Med 2024; 102: 610–615.
  3. Goldacre R, Trubshaw M, Morris EJA, et al. Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study. J Neurol Neurosurg Psychiatry 2024; jnnp-2024-333399.
  4. Lu C-H, Allen K, Oei F, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation; 3. Epub ahead of print August 2016. DOI: 10.1212/NXI.0000000000000244.
  5. Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism. Front Pediatr; 6. Epub ahead of print 23 May 2018. DOI: 10.3389/fped.2018.00142.
  6. Fukui Y, Hishikawa N, Shang J, et al. Peripheral arterial endothelial dysfunction of neurodegenerative diseases. J Neurol Sci 2016; 366: 94–99.